相似文献
1
Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity.
Cancers (Basel). 2024 Feb 19;16(4):829. doi: 10.3390/cancers16040829.
2
Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Front Immunol. 2023 Oct 16;14:1238312. doi: 10.3389/fimmu.2023.1238312. eCollection 2023.
3
RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
Cancer Med. 2023 Apr;12(8):9788-9801. doi: 10.1002/cam4.5723. Epub 2023 Feb 27.
4
Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Pathol Res Pract. 2021 Sep;225:153557. doi: 10.1016/j.prp.2021.153557. Epub 2021 Jul 20.
5
Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Am J Surg Pathol. 2016 Feb;40(2):141-54. doi: 10.1097/PAS.0000000000000583.
6
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.
Virchows Arch. 2014 Oct;465(4):439-44. doi: 10.1007/s00428-014-1648-9. Epub 2014 Sep 2.
7
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
8
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
Nat Commun. 2022 Apr 19;13(1):2052. doi: 10.1038/s41467-022-29577-x.
9
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Dan Med J. 2017 Oct;64(10).
10
Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study.
Medicine (Baltimore). 2022 Dec 23;101(51):e30658. doi: 10.1097/MD.0000000000030658.
引用本文的文献
1
Hot Spots in Urogenital Basic Cancer Research and Clinics.
Cancers (Basel). 2025 Mar 31;17(7):1173. doi: 10.3390/cancers17071173.
2
A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma.
Oncology. 2025;103(4):341-350. doi: 10.1159/000541370. Epub 2024 Sep 9.
本文引用的文献
1
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival.
Cancers (Basel). 2024 Jan 28;16(3):557. doi: 10.3390/cancers16030557.
2
Targeting NPC1 in Renal Cell Carcinoma.
Cancers (Basel). 2024 Jan 25;16(3):517. doi: 10.3390/cancers16030517.
3
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Cancers (Basel). 2024 Jan 23;16(3):490. doi: 10.3390/cancers16030490.
4
Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery.
Cancers (Basel). 2024 Jan 23;16(3):478. doi: 10.3390/cancers16030478.
5
Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study.
Cancers (Basel). 2023 Dec 24;16(1):97. doi: 10.3390/cancers16010097.
6
Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2023 Dec 11;15(24):5797. doi: 10.3390/cancers15245797.
7
Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring.
Cancers (Basel). 2023 Oct 11;15(20):4934. doi: 10.3390/cancers15204934.
8
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.
Cancer Drug Resist. 2023 Aug 2;6(3):517-546. doi: 10.20517/cdr.2023.33. eCollection 2023.
9
Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2023 Sep 26;15(19):4734. doi: 10.3390/cancers15194734.
10
Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
Cell Commun Signal. 2023 Sep 18;21(1):234. doi: 10.1186/s12964-023-01204-2.
Zotero 插件